Skip to content

Mobile Communication Technology for Adolescents With Diabetes

Adapting Mobile Communication Technology to Improve the Management of Adolescents With Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00605839
Enrollment
105
Registered
2008-01-31
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

mobile technology, cell phones, type 1 diabetes

Brief summary

Among those with type I diabetes, adolescents can be among the worst at achieving glycemic control. Behaviors normal in adolescent development (e.g., developing independence, rejecting parental norms in favor of peers) can be at odds with the demands of effective diabetes self-management. Modifying the family and patient interaction should be a crucial component to improving the ability of an adolescent to manage his or her diabetes. Mobile technology is becoming more popular in medicine, and adolescents, as a group are more inclined to accept technology as an adjunct to care. Mobile technology that links adolescents to health providers could help them to work through complex information that must be processed to make good decisions. Since this assistance comes from health professionals, it should help relax parents somewhat, thus reducing problems associated with parental hypervigilance and manipulation of the regimen to avoid problems of hypoglycemia. Parental-child conflicts may therefore be reduced by using cell phone glucose monitoring technology that directly reports self-blood glucose monitoring data to providers and creates a communication link to discuss therapeutic options. This study investigates whether the use of mobile technology, in the form of a cell phone glucose monitoring system, will help reduce the need for parents to assert behavioral control, which can negatively impact adolescent diabetes self-management. The study will also determine whether adolescents report improved quality of life, demonstrate competence in diabetes management, and are able to achieve better control of their diabetes.

Detailed description

Among patients with type I diabetes, adolescents struggle the most with self-management, which often results in poor glycemic control. Optimizing parent-patient interaction is crucial to improving self-management. Mobile technology with integrated glucose monitoring capability that links adolescents to providers may reduce parental hypervigilance and assist them to better understand self-management. . This study will investigate a novel cell phone glucose monitoring system (CPGM) with the following specific aims: 1. To establish feasibility of a CPGM system as a component of an adolescent diabetes management program. 2. To determine if the technology will improve a) quality of parent-child relationship, b) patient quality of life, c) competence in diabetes management, and d) metabolic control. 3. To gather preliminary data for development of future intervention studies. 120 adolescents with type I diabetes will be randomly assigned to either an experimental or control group. Experimental subjects will use the CPGM which will transmit all blood glucose data to a host computer. A nurse practitioner in the pediatric endocrinology clinic will determine need for telephone contacts based on evaluation of transmitted data. Subjects might be telephoned to discuss possible regimen adjustments, need for clinic visits, or referrals to additional services. Subjects will also be able to initiate contact with the project nurse. Control subjects will continue to receive standard care. . This study will assess the effect of the intervention in the four primary domains stated in the specific aims. These domains will be measured at baseline, three months, and six months.

Interventions

DEVICEGlucoPak

We will be giving participants Glucopak devices and monitoring them closely over the 6 month period.

We will provide cell phones and access to the clinic to facilitate communications

OTHERUsual Care

This intervention was usual care, without either device.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Adolescent with thpe 1 diabetes 2. Adolescents in the study must intend to remain in the care of participating clinics for the extent of the study 3. Adolescents in the study must be literate in English.

Exclusion criteria

1. Only one patient per family can participate 2. Patients who participated in preliminary studies related to the development of the cell phone technology will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Quality of Parent-child RelationshipChange from baseline to 6 months. Please see above for a description of how the change score should be interpreted.The Cornell Parent Behavior Description Scale was used to measure the antecedents and consequences of children's perceptions of the behavior of their parents towards them. Each of 14 subscales is scored from 0-10. The potential range of the total score is therefore 0 (fewest behaviors) to 140 (most behaviors). We used the total score, which is equivalent to the sums of the subscales, and calculated the change from baseline to 6 months. The range of the change is given as a 95% CI. A change of zero would indicate no change. A positive number is a worsening , and a negative number indicates an improvement.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from the pediatric diabetes clinics at the James Whitcomb Riley Hospital for Children in Indianapolis, IN. Adolescents with type 1 diabetes between the ages of 14 and 18 years living with at least one parent participated.

Participants by arm

ArmCount
Glucopak Cell Phone and Intensive Monitoring
Glucopak cell phone and intensive monitoring. This group will be given the experimental device, and placed in close communication with the clinic.
40
Cell Phone Only
Cell phone only, without the Glucopak. Participants will be given cell phones and encouraged to communicate more closely with the clinic, but will not use the Glucopak.
37
Usual Care
Usual care, without cell phone or glucopak
28
Total105

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyProtocol Violation100

Baseline characteristics

CharacteristicGlucopak Cell Phone and Intensive MonitoringCell Phone OnlyUsual CareTotal
Age, Categorical
<=18 years
40 Participants37 Participants28 Participants105 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
United States
40 participants37 participants28 participants105 participants
Sex: Female, Male
Female
20 Participants20 Participants13 Participants53 Participants
Sex: Female, Male
Male
20 Participants17 Participants15 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 390 / 370 / 28
serious
Total, serious adverse events
0 / 390 / 370 / 28

Outcome results

Primary

Quality of Parent-child Relationship

The Cornell Parent Behavior Description Scale was used to measure the antecedents and consequences of children's perceptions of the behavior of their parents towards them. Each of 14 subscales is scored from 0-10. The potential range of the total score is therefore 0 (fewest behaviors) to 140 (most behaviors). We used the total score, which is equivalent to the sums of the subscales, and calculated the change from baseline to 6 months. The range of the change is given as a 95% CI. A change of zero would indicate no change. A positive number is a worsening , and a negative number indicates an improvement.

Time frame: Change from baseline to 6 months. Please see above for a description of how the change score should be interpreted.

Population: Everyone who completed the study

ArmMeasureValue (MEAN)
Glucopak Cell Phone and Intensive MonitoringQuality of Parent-child Relationship0.22 units on a scale
Cell Phone OnlyQuality of Parent-child Relationship-3.24 units on a scale
Usual CareQuality of Parent-child Relationship-0.59 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026